- Advanced search
- Immuno Portal
- Malaria Portal
Molecular properties generated using the CDK
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|Compound class||Synthetic organic|
|International Nonproprietary Names|
|AZD-0530 | AZD0530|
|Saracatinib was developed as an inhibitor of Src family tyrosine kinases. This compound is now included in AstaZeneca's Open Innovation Pharmacology Toolbox.
Note that some bioactivity data may be associated with the difumarate salt (PubChem CID 44195703).
Saracatinib (AZD0530) is compound 33 in .
|CAS Registry No.||379231-04-6|
|GtoPdb PubChem SID||223366064|
|RCSB PDB Ligand||H8H|
|Search Google for chemical match using the InChIKey||OUKYUETWWIPKQR-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||OUKYUETWWIPKQR|
|Search PubMed clinical trials||saracatinib|
|Search PubMed titles||saracatinib|
|Search PubMed titles/abstracts||saracatinib|
|Search UniChem for chemical match using the InChIKey||OUKYUETWWIPKQR-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||OUKYUETWWIPKQR|
|SynPHARM||80251 (in complex with SRC proto-oncogene, non-receptor tyrosine kinase)|